Interstitial high-dose rate brachytherapy as boost for anal canal cancer

[1] Faivre J(2012)Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002 Eur J Cancer 48 1417-1424

[2] Trama A(1997)Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol Off J Am Soc Clin Oncol 15 2040-2049

[3] De Angelis R(1996)Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research Lancet 348 1049-1054

[4] Elferink M(2010)Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I) Br J Cancer 102 1123-1128

[5] Siesling S(2009)Elective clinical target volumes for conformal therapy in anorectal cancer: an RTOG consensus panel contouring atlas Int J Radiat Oncol Biol Phys 74 824-830

[6] Audisio R(2001)High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study Ann Oncol 12 397-404

[7] Bosset JF(2013)RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal Int J Radiat Oncol Biol Phys 86 27-33

[8] Cervantes A(1989)Interstitial curietherapy in the conservative treatment of anal and rectal cancers Int J Radiat Oncol 17 1161-1169

[9] Lepage C(2006)Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: A retrospective study Radiother Oncol 79 75-79

[10] Bartelink H(2013)GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update Radiother Oncol J Eur Soc Ther Radiol Oncol 107 325-332

[1] Faivre J(2012)Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002 Eur J Cancer 48 1417-1424

[2] Trama A(1997)Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol Off J Am Soc Clin Oncol 15 2040-2049

[3] De Angelis R(1996)Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research Lancet 348 1049-1054

[4] Elferink M(2010)Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I) Br J Cancer 102 1123-1128

[5] Siesling S(2009)Elective clinical target volumes for conformal therapy in anorectal cancer: an RTOG consensus panel contouring atlas Int J Radiat Oncol Biol Phys 74 824-830

[6] Audisio R(2001)High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study Ann Oncol 12 397-404

[7] Bosset JF(2013)RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal Int J Radiat Oncol Biol Phys 86 27-33

[8] Cervantes A(1989)Interstitial curietherapy in the conservative treatment of anal and rectal cancers Int J Radiat Oncol 17 1161-1169

[9] Lepage C(2006)Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: A retrospective study Radiother Oncol 79 75-79

[10] Bartelink H(2013)GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update Radiother Oncol J Eur Soc Ther Radiol Oncol 107 325-332